Monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia
نویسندگان
چکیده
منابع مشابه
Dopamine Agonist Therapy in Advanced Parkinson’s Disease
“Parkinson’s disease (PD) doesn’t kill you, it takes your life away.” This is a disturbing quotation by the English Parkinson Lay Organisation. There is, however, no other neurodegenerative disease which responds better to treatment than PD. Treatment of advanced PD is located between these poles (Figure 1). Most national guidelines and papers on the treatment of PD recommended that early phase...
متن کاملMonitoring patients with implanted cardiac rhythm devices receiving radiation therapy.
629 D iagnosed in 2007 with chronic lymphocytic leukemia (CLL), S.B. was a 78-year-old man. Treatment consisted of a course of rituxumab with stable blood counts. About two years after the initial diagnosis, S.B. presented with a moderately rapidly enlarging mass in his left-anterior shoulder. Biopsy of the mass revealed a Merkel cell carcinoma and, within a month, another mass was noted in his...
متن کاملTransient occult cardiotoxicity in children receiving continuous beta-agonist therapy.
BACKGROUND Continuous beta-agonist therapy, typically in the form of inhaled albuterol, is the first line therapy for the treatment of acute and severe bronchospasm in children. Although this treatment is commonly used, concerns about cardiotoxicity have been raised. We aimed to investigate the cardiotoxic effects of continuous beta-agonist therapy in children. METHODS We conducted a retrospe...
متن کاملCaring for patients receiving oxygen therapy.
Although respiratory disease can occur at any age, older people are more likely to suffer both acute and chronic respiratory disease. Without sufficient oxygen, cells fail and die, and extensive cell death causes body systems to fail. This article considers the principles of short-term oxygen therapy and offers guidance to nurses who may be required to administer such treatment in their work wi...
متن کاملImpulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
BACKGROUND Impulse control disorders (ICDs) encompass a wide spectrum of abnormal behaviour frequently found in cases of Parkinson's disease (PD) treated with dopamine agonists (DAs). The main aim of this study was to analyse ICD prevalence with different DAs. METHODS We carried out a multicentre transversal study to evaluate the presence of ICDs in patients with PD chronically treated (>6 mo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annales d'Endocrinologie
سال: 2021
ISSN: 0003-4266
DOI: 10.1016/j.ando.2020.02.007